A new study of neurodevelopmental delay risks following paternal valproate use has been published. More information is available here. Photo by nappy, downloaded from Pexels.
» Read more
Professor Per Damkier (the outgoing Chair of the ENTIS Scientific Committee) and Dr Matitiahu Berkovitch (President of ENTIS) have published a commentary in the British Journal of Obstetrics and Gynaecology discussing the FDA panel discussion (broadcast 21 July 2025) about the safety of selective serotonin reuptake inhibitors (SSRI) in pregnancy. Photo by Sam Szuchan on Unsplash
» Read more
Researchers from Liverpool University have published an umbrella review of systematic reviews investigating maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder. The authors concluded that confidence in the current evidence was considered low to critically low. More information is available here. Photo by James Yarema on Unsplash
» Read more
A nationwide, register-based, case-control study, using linked Norwegian population-level administrative data has identified associations between ADHD medication use in early pregnancy and miscarriage. More information is available here. Photo by Lance Reis on Unsplash
» Read more
Researchers have analysed data from the Teva Pharmaceutical Industries modafinil/armodafinil pregnancy exposure registry, to provide a final analysis of dataset. The registry describes a high incidence of major congenital malformation (13.1%). More details available here.
» Read more
ENTIS members Prof Per Damkier and Dr Erika Gram have published a commentary discussing the methodological advantages and limitations of a new study of Commentary published discussing a recent study of acetaminophen exposure and childhood attention deficit hyperactivity disorder (Baker et al. 2025 – see here). Photo by Tara Winstead downloaded from Pexels
» Read more
Researchers affiliated with the Hamamatsu University School of Medicine in Japan have published a systematic review and meta-analysis of observational studies which investigated the association between prenatal ZIKV exposure and neurodevelopmental outcomes in offspring without congenital anomalies at birth. More information can be found here.
» Read more
Researchers with access to the Pfizer Global Safety Database have updated their descriptive analysis of pregnancy outcomes following maternal or paternal tofacitinib use. More information available here. Photo by Sasun Bughdaryan on Unsplash
» Read more
ENTIS does not support the recent claims relating to autism risk following paracetamol use in pregnancy
» Read more
